BRIEF published on 07/06/2026 at 20:05, 1 month 16 days ago ABIONYX: Details on Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 1 month 16 days ago ABIONYX Monthly Voting Rights Update Euronext Paris Share Capital Voting Rights Financial Update ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 20:00, 1 month 16 days ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares. Company focuses on innovative medicines development with lipid science expertise Shares Total Voting Rights ABIONYX Pharma Innovative Medicines Lipid Science
BRIEF published on 07/06/2026 at 19:19, 1 month 16 days ago ABIONYX's Half-Yearly Review of the Liquidity Contract Liquidity Transactions TP ICAP Actions ABIONYX Pharma
BRIEF published on 06/30/2026 at 19:13, 1 month 22 days ago ABIONYX Pharma is expanding rapidly following its General Meeting ABIONYX Pharma Sepsis CER-001 General Assembly 2026 ApoA-I Platform
BRIEF published on 06/30/2026 at 19:13, 1 month 22 days ago ABIONYX Pharma Secures Funding to Advance Sepsis Treatment ABIONYX Pharma CER-001 Financial Funding Sepsis Treatment ApoA-I Platform
PRESS RELEASE published on 06/30/2026 at 19:08, 1 month 22 days ago Inside Information / Other news releases ABIONYX Pharma scales up operations after securing resources, focusing on value creation in inflammation and sepsis treatment. Updates on pivotal clinical trial, financial visibility, and scientific platform development Financial Resources Clinical Trial ABIONYX Pharma Sepsis Inflammation Treatment
BRIEF published on 06/18/2026 at 07:35, 2 months 5 days ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
BRIEF published on 06/18/2026 at 07:35, 2 months 5 days ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
PRESS RELEASE published on 06/18/2026 at 07:30, 2 months 5 days ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
Published on 08/22/2026 at 05:50, 1 day 12 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 1 day 13 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 1 day 18 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 1 day 19 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 1 day 19 hours ago Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott
Published on 08/21/2026 at 19:36, 1 day 23 hours ago EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 1 day 23 hours ago EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 17:27, 2 days 1 hour ago EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 2 days 2 hours ago BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
Published on 08/18/2026 at 11:15, 5 days 7 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 5 days 22 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 6 days 10 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
